Agenus Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.47%81.210.9%$648.72m
CELGCelgene Corporation
-10.76%121.331.1%$640.82m
AMGNAmgen Inc.
-0.63%182.961.1%$453.41m
BIIBBiogen Inc.
-1.26%338.101.2%$410.25m
REGNRegeneron Pharmaceuticals, Inc.
-1.81%432.982.7%$314.62m
VRTXVertex Pharmaceuticals Incorporated
0.02%154.631.9%$217.79m
INCYIncyte Corporation
-0.07%114.192.5%$202.03m
ALXNAlexion Pharmaceuticals, Inc.
-1.08%138.941.9%$183.38m
ALNYAlnylam Pharmaceuticals, Inc
-0.82%114.6810.7%$157.13m
EXELExelixis, Inc.
-1.06%27.176.5%$135.00m
ILMNIllumina, Inc.
2.29%209.883.5%$132.21m
BLUEBluebird Bio, Inc.
2.22%142.5517.3%$118.24m
BMRNBioMarin Pharmaceutical Inc.
-0.43%87.754.4%$113.37m
SRPTSarepta Therapeutics, Inc.
2.41%51.9416.9%$108.74m
CLVSClovis Oncology, Inc.
0.95%77.5016.5%$103.06m

Company Profile

Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.